Deirdre Mladsi

741 total citations
31 papers, 506 citations indexed

About

Deirdre Mladsi is a scholar working on Surgery, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Deirdre Mladsi has authored 31 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Deirdre Mladsi's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Hedgehog Signaling Pathway Studies (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Deirdre Mladsi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Hedgehog Signaling Pathway Studies (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Deirdre Mladsi collaborates with scholars based in United States, Switzerland and United Kingdom. Deirdre Mladsi's co-authors include Ken Redekop, Trong Kim Le, Dawn Odom, James A. Kaye, Naoko Ronquest, Susan Martin, Kenneth G. Saag, Dalila Sellami, Bintu Sherif and Jianmin Wang and has published in prestigious journals such as Blood, Neurology and Clinical Therapeutics.

In The Last Decade

Deirdre Mladsi

29 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deirdre Mladsi United States 9 170 93 82 80 60 31 506
Aodán Tynan Ireland 8 118 0.7× 39 0.4× 147 1.8× 87 1.1× 84 1.4× 8 917
Hye‐Young Kim South Korea 13 87 0.5× 61 0.7× 59 0.7× 63 0.8× 13 0.2× 55 480
Kiwon Kim South Korea 16 63 0.4× 112 1.2× 152 1.9× 163 2.0× 12 0.2× 40 773
Aliya Sarmanova United Kingdom 16 357 2.1× 36 0.4× 95 1.2× 408 5.1× 22 0.4× 37 1.2k
Surabhi Bhatt United States 10 128 0.8× 201 2.2× 60 0.7× 301 3.8× 21 0.3× 17 513
Toshinobu Matsui Japan 10 100 0.6× 43 0.5× 58 0.7× 20 0.3× 10 0.2× 16 422
Immacolata Esposito Italy 9 29 0.2× 34 0.4× 170 2.1× 99 1.2× 30 0.5× 37 634
Jing Bai China 13 72 0.4× 25 0.3× 78 1.0× 125 1.6× 10 0.2× 44 725
Arti D. Shah United States 10 40 0.2× 82 0.9× 88 1.1× 110 1.4× 12 0.2× 17 785

Countries citing papers authored by Deirdre Mladsi

Since Specialization
Citations

This map shows the geographic impact of Deirdre Mladsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deirdre Mladsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deirdre Mladsi more than expected).

Fields of papers citing papers by Deirdre Mladsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deirdre Mladsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deirdre Mladsi. The network helps show where Deirdre Mladsi may publish in the future.

Co-authorship network of co-authors of Deirdre Mladsi

This figure shows the co-authorship network connecting the top 25 collaborators of Deirdre Mladsi. A scholar is included among the top collaborators of Deirdre Mladsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deirdre Mladsi. Deirdre Mladsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mladsi, Deirdre, et al.. (2024). Mortality risk in patients with autosomal dominant polycystic kidney disease. BMC Nephrology. 25(1). 56–56. 2 indexed citations
2.
3.
4.
Mladsi, Deirdre, et al.. (2020). <p>Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease</p>. ClinicoEconomics and Outcomes Research. Volume 12. 515–526. 5 indexed citations
5.
6.
Martin, Susan, et al.. (2020). <p>The Humanistic and Economic Burden of Chronic Idiopathic Constipation in the USA: A Systematic Literature Review</p>. Clinical and Experimental Gastroenterology. Volume 13. 255–265. 28 indexed citations
7.
Gould, Ian, et al.. (2020). <p>US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma</p>. ClinicoEconomics and Outcomes Research. Volume 12. 317–325. 5 indexed citations
8.
Lucas, A. O., et al.. (2019). A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States. Cost Effectiveness and Resource Allocation. 17(1). 21–21. 6 indexed citations
9.
Mladsi, Deirdre, et al.. (2018). PSY2 - IDENTIFICATION OF POTENTIAL BIAS FROM DATA SOURCES AND STUDY DESIGNS USED TO ESTIMATE PLATELET TRANSFUSION ADVERSE EVENT RATES. Value in Health. 21. S436–S436. 1 indexed citations
10.
Mladsi, Deirdre, et al.. (2018). Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy. Advances in Therapy. 35(10). 1686–1696. 22 indexed citations
11.
Mladsi, Deirdre, et al.. (2017). An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia. Hospital Practice. 45(3). 111–117. 4 indexed citations
12.
13.
14.
Odom, Dawn, et al.. (2016). A Matching Adjusted Indirect Comparison Of Sonidegib And Vismodegib In Advanced Basal Cell Carcinoma. Value in Health. 19(3). A122–A122. 2 indexed citations
15.
Mladsi, Deirdre, et al.. (2016). Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac. Clinical Therapeutics. 38(11). 2418–2429.
16.
17.
Mladsi, Deirdre, et al.. (2014). An Outcomes Model for High-Risk Non-Muscle-Invasive Bladder Cancer Treatment Options. Value in Health. 17(3). A87–A87. 1 indexed citations
18.
Redekop, Ken & Deirdre Mladsi. (2013). The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope. Value in Health. 16(6). S4–S9. 125 indexed citations
19.
Le, Trong Kim, et al.. (2009). The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opinion on Pharmacotherapy. 10(16). 2581–2592. 176 indexed citations
20.
Mladsi, Deirdre, et al.. (2004). Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Current Medical Research and Opinion. 20(12). 1883–1893. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aodán Tynan Breakdown of academic impact, for papers by Hye‐Young Kim Breakdown of academic impact, for papers by Kiwon Kim Breakdown of academic impact, for papers by Aliya Sarmanova Breakdown of academic impact, for papers by Surabhi Bhatt Breakdown of academic impact, for papers by Toshinobu Matsui Breakdown of academic impact, for papers by Immacolata Esposito Breakdown of academic impact, for papers by Jing Bai Breakdown of academic impact, for papers by Arti D. Shah
Rankless by CCL
2026